Peter J. Mccormick
Charterhouse Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Corrigendum to "Histamine H1 receptor: a potential therapeutic target for pancreatic ductal adenocarcinoma".
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 07, 2026
β-Arrestins and disease-linked variants: opportunities for targeted modulation.
Journal: Trends in pharmacological sciences
Published: October 30, 2025
Histamine H1 Receptor: A potential therapeutic target for pancreatic ductal adenocarcinoma.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 16, 2025
Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed.
Journal: Function (Oxford, England)
Published: October 20, 2024
Structural and dynamic insights into agonist recognition and function of the thromboxane A2 receptor.
Journal: Nature communications
Published: October 04, 2024
Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis.
Journal: ACS pharmacology & translational science
Published: September 10, 2024
MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.
Journal: Nature communications
Published: May 28, 2024
A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR.
Journal: Nature communications
Published: May 06, 2024
Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy.
Journal: Journal of structural biology
Published: May 06, 2024
Correction to: A1R-A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes.
Journal: Purinergic signalling
Published: April 26, 2024
Multiomics reveal key inflammatory drivers of severe obesity: IL4R, LILRA5, and OSM.
Journal: Cell genomics
Published: April 25, 2024
Last Updated: 09/26/2026